TABLE 4.

Prevalence of epilepsy in D2D surveys in sub‐Saharan Africa

Country	Study year	Sample size	Active/lifetime epilepsy	Prevalence	Age limit (y)	PwE#F/#M	PwE F/M ratio	Prevalence male (‰)	Prevalence female (‰)
Benin–Cotonou	2012	13,046	Active < 5 y	Crude	≥15	51/54	0.94:1.00	9.8	6.8
Ghana–Kintampo	2013	129,812	Active < 1 y	Age‐adjusted	All	ND	ND	11.1	9.1
Cameroon–Keleng	2008	181	Active < 5 y	Age‐adjusted	All	9/10	0.90:1.00	123	90
Central African Republic	2015	1023	Lifetime	Crude	All	6/6	1.00:1.00	13.0	10.7
Kenya	2003	151,408	Active < 1 y	Crude	≥6	220/225	0.97:1.00	3.2	2.7
Kenya–Kilifi	2007–2008	233,881	Active < 1 y	Age‐adjusted	All	ND	0.92:1.00	7.0	8.6
Tanzania–Hai	2009–2010	103,026	Active < 5 y	Crude	≥15	136/155	0.91:1.00	3.2	2.5
Tanzania	1999	4905	Active < 5 y	Age‐adjusted	All	21/21	1.00:1.00	7.5	7.2
Tanzania	2009	7399	Lifetime	Crude	All	52/31	1.46:1.00	8.4	14.3
Tanzania–Ifakara	2009	93,645	Active < 1 y	Age‐adjusted	All	ND	ND	14.0	10.9
Uganda–Iganga‐Mayuge	2009	64,172	Active < 1 y	Age‐adjusted	All	ND	ND	8.9	9.6
South Africa–Agincourt	2008–2009	82,818	Active < 1 y	Age‐adjusted	All	ND	ND	6.6	7.6

Abbreviations: #, number; ‰, per thousand; F, female; M, male; ND, not documented; y, year.